Submitted by Anonymous (not verified) on 27 May 2026 - 11:30
Human medicines European public assessment report (EPAR): Rezdiffra, resmetirom, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rezdiffra, resmetirom, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised